Drug intelligence / Profile preview

iso-1

Development stage
Preclinical
Lead developer
Soochow University
Modality
Small Molecules
Administration
Oral (preclinical), Intraperitoneal (preclinical)
01

Overview

ISO-1 is a small molecule inhibitor of macrophage migration inhibitory factor (MIF), specifically inhibiting its D-dopachrome tautomerase activity with an IC50 of approximately 7 μM[1][7]. It binds to the active site of MIF and blocks its biological activities, including pro-inflammatory signaling. ISO-1 has demonstrated protective effects in various preclinical models such as sepsis, diabetes mellitus, asthma (airway remodeling), and inflammatory/fibrotic lung disease[5][7]. It is cell-permeable and orally bioavailable. The compound has been shown to cross the blood-brain barrier and suppresses inflammatory responses in several animal models. Its primary mechanism is antagonism of MIF-mediated pathways involved in immune regulation and inflammation[5][6].

Other names
MIF Antagonistmethyl 2-[3-(4-hydroxyphenyl)-4,5-dihydroisoxazol-5-yl]acetate4,5-dihydro-3-(4-hydroxyphenyl)-5-isoxazoleacetic acid, methyl ester
02

Targets

MIF (Oxidized macrophage migration inhibitory factor)

Beyond the preview

Go deeper on iso-1.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on iso-1.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call